Effect of Solutions Used in Burn Wound Irrigation on Healing, Pain, Fear and Anxiety: Randomized Controlled Study
Launched by NURDAN AKCAY DİDİSEN · Apr 16, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different solutions used to clean burn wounds affect healing, pain, fear, and anxiety in children. Specifically, it will compare three antiseptic solutions: saline (salt water), chlorhexidine, and hypochlorous acid. The goal is to find out which solution is the least painful and most effective for healing burns, while also looking at how these solutions impact the children's feelings of anxiety and fear during treatment.
To participate in this study, children aged 5 to 10 who have suffered burns from hot water and are being treated as outpatients at a burn clinic may be eligible. They need to have superficial or deep burns on their arms, legs, or torso, and both the child and their parent must agree to join the study. Throughout the trial, children will visit the clinic every three days for dressing changes, where their pain, anxiety, and healing progress will be monitored. This research aims to improve the way we care for burn wounds in children, ensuring a more comfortable and effective treatment process.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: The child must be between the ages of 5-10, be followed up in the burn clinic of the pediatric surgery service, be conscious, alert, and open to communication, be a child with 10% or 2nd degree superficial and deep burns who are being followed up as an outpatient, have burns on the arms, legs, and torso, have hot water (boiling water, etc.) burns, and the parent and child must agree to participate in the study.
- • Exclusion Criteria: The child must be younger than 5 years old or older than 10 years old, have a general condition disorder due to burns, have a change in consciousness, have genital area and facial burns, have a 10% or more second and third degree burn, have a burn that is an indication for hospitalization, the parent uses topical agents for burn healing at home, and the parent and child do not accept to participate in the study.
About Nurdan Akcay Di̇di̇sen
Nurdan Akcay Didisen is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a strong focus on innovative therapies and evidence-based practices, the organization collaborates with healthcare professionals and research institutions to conduct rigorous clinical trials. Nurdan Akcay Didisen prioritizes ethical standards and regulatory compliance, ensuring the safety and well-being of participants while contributing to the body of scientific knowledge. Through meticulous planning and execution, the sponsor aims to bring transformative treatments to market, addressing unmet medical needs across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported